Literature DB >> 8571424

Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease.

H Touho1, J Karasawa, H Ohnishi.   

Abstract

BACKGROUND AND
PURPOSE: The results of long-term follow-up studies of cerebral perfusion and vasodilatory capacity following administration of acetazolamide after serial vascular reconstructions in 25 patients with childhood moyamoya disease are reported.
METHODS: Cerebral perfusion was measured with 99mTc-hexamethylpropyleneamine oxime single-photon emission CT before and after IV administration of 10 mg/kg acetazolamide, which was performed both before and after vascular reconstruction by superficial temporal artery-middle cerebral artery anastomosis and encephalomyosynangiosis (first and second operations) and/or omental transplantation to the brain (third operation).
RESULTS: Follow-up periods ranged between 12 and 24 months (mean +/- SD, 18.5 +/- 3.2 months) after the first operation. Repetitive transient ischemic attacks disappeared completely after serial vascular reconstructions in all patients. Before the first operation, cerebral perfusion in the territory of the middle cerebral artery on the side of initial operation was 83.9 +/- 4.7% and was significantly lower than that in the contralateral side (88.3 +/- 4.9%, n = 25; P < .0001, paired t test). Vasodilatory capacity on the side of the first operation was -18.4 +/- 2.5% and that on the contralateral side -14.4 +/- 2.1%. The former value was significantly lower than the latter value (n = 25; P < .0001, paired t test). After the first operation, cerebral perfusion and vasodilatory capacity on the side of initial operation were markedly improved, to 87.8 +/- 4.5% and -14.7 +/- 2.7%, respectively (n = 25; P < .0001, both cases, paired t test). Before the second operation, cerebral perfusion and vasodilatory capacity on the side of the second operation were 76.6 +/- 4.1% and -20.1 +/- 1.9%, respectively, and significantly lower than those before the first operation (n = 25; P < .0001, both cases, paired t test). Eight patients subsequently required bifrontal omental transplantation for repetitive paraparetic transient ischemic attacks after the second operation; they had low cerebral perfusion and vasodilatory capacity bilaterally in the territories of the anterior cerebral arteries (72.4 +/- 2.7% and -18.6 +/- 1.7%, respectively). After omental transplantation, both were significantly increased, to 81.9 +/- 3.4% and -11.8 +/- 1.9%, respectively (n = 25; P < .0001, both cases, paired t test).
CONCLUSIONS: Hemodynamic compromise existed in patients with childhood moyamoya disease and was a major cause of development of ischemic symptoms. Regions in which hemodynamic compromise was present could be determined by measuring regional cerebral perfusion and vasodilatory capacity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8571424     DOI: 10.1161/01.str.27.2.282

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  18 in total

1.  Localized 1H-MR spectroscopy in moyamoya disease before and after revascularization surgery.

Authors:  Soo Mee Lim; Hye-Young Choi; Jung Soo Suh; Jung Hee Lee; Keun Ho Lim; Dae Chul Suh; Ho Kyu Lee; Tae-Hwan Lim; Young Shin Ra
Journal:  Korean J Radiol       Date:  2003 Apr-Jun       Impact factor: 3.500

Review 2.  Quantitative hemodynamic studies in moyamoya disease: a review.

Authors:  Marco Lee; Greg Zaharchuk; Raphael Guzman; Achal Achrol; Teresa Bell-Stephens; Gary K Steinberg
Journal:  Neurosurg Focus       Date:  2009-04       Impact factor: 4.047

3.  Comparison of CBF Measured with Combined Velocity-Selective Arterial Spin-Labeling and Pulsed Arterial Spin-Labeling to Blood Flow Patterns Assessed by Conventional Angiography in Pediatric Moyamoya.

Authors:  D S Bolar; B Gagoski; D B Orbach; E Smith; E Adalsteinsson; B R Rosen; P E Grant; R L Robertson
Journal:  AJNR Am J Neuroradiol       Date:  2019-11-06       Impact factor: 3.825

4.  Patient selection for revascularization procedures in adult Moyamoya disease based on dynamic perfusion computerized tomography with acetazolamide challenge (PCTA).

Authors:  Norberto Andaluz; Ondrej Choutka; Achala Vagal; Rhonda Strunk; Mario Zuccarello
Journal:  Neurosurg Rev       Date:  2010-02-06       Impact factor: 3.042

5.  Extensive brain infarction involving deep structures during an acetazolamide-challenged single-photon emission computed tomography scan in a patient with moyamoya disease.

Authors:  Sangjoon Chong; June Dong Park; Jong Hee Chae; Jung-Eun Cheon; Seung-Ki Kim; Ji Hoon Phi; Ji Yeoun Lee; Jin Chul Paeng; Kyu-Chang Wang
Journal:  Childs Nerv Syst       Date:  2017-07-08       Impact factor: 1.475

6.  Expression of vascular endothelial growth factor in dura mater of patients with moyamoya disease.

Authors:  Shigeyuki Sakamoto; Yoshihiro Kiura; Fumiyuki Yamasaki; Masaaki Shibukawa; Shinji Ohba; Prabin Shrestha; Kazuhiko Sugiyama; Kaoru Kurisu
Journal:  Neurosurg Rev       Date:  2007-10-03       Impact factor: 3.042

7.  Postoperative evaluation of moyamoya disease with perfusion-weighted MR imaging: initial experience.

Authors:  Seung-Koo Lee; Dong Ik Kim; Eun-Kee Jeong; Si-Yeon Kim; Sang Heum Kim; Yon Kwon In; Dong-Seok Kim; Joong-Uhn Choi
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

8.  Impact of blood pressure changes in cerebral blood perfusion of patients with ischemic Moyamoya disease evaluated by SPECT.

Authors:  Zhao Liming; Sun Weiliang; Jia Jia; Liang Hao; Liu Yang; Christopher Ludtka; Behnam Rezai Jahromi; Felix Goehre; Ajmal Zemmar; Li Tianxiao; Juha Hernesniemi; Hugo Andrade-Barazarte; Li Chaoyue
Journal:  J Cereb Blood Flow Metab       Date:  2020-11-05       Impact factor: 6.200

9.  Qualitative versus quantitative assessment of cerebrovascular reactivity to acetazolamide using iodine-123-N-isopropyl-p-iodoamphetamine SPECT in patients with unilateral major cerebral artery occlusive disease.

Authors:  Kuniaki Ogasawara; Taku Okuguchi; Masayuki Sasoh; Masakazu Kobayashi; Hirotsugu Yukawa; Kazunori Terasaki; Takashi Inoue; Akira Ogawa
Journal:  AJNR Am J Neuroradiol       Date:  2003 Jun-Jul       Impact factor: 3.825

10.  Cerebral-perfusion-based single-photon emission computed tomography (SPECT) staging using NeuroGam® in patients with moyamoya disease.

Authors:  Jai-Hyuck Han; Young Seok Park; Won Hyoung Lee; Sung-Soo Koong; Kyung-Soo Min; Mou-Seop Lee; Young-Gyu Kim; Dong-Ho Kim; Kyung-Sil Yi; Sang-Hoon Cha
Journal:  Childs Nerv Syst       Date:  2015-12-11       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.